Vax-D Treatment Center of Alaska is categorized under Chiropractors in Anchorage, AK .
Vax-D Treatment Center of Alaska was established in 0, and today employs 1 to 4, earning $500.000 to $999.999 per year. This is a Chiropractors business, which does work in the B2C market, and is classified as a Chiropractors, under code number 6213100 by the NAICS.
If you are seeking more information, feel free to contact Christopher Hogan, Owner at the company’s single location by writing to 1100 East Northern Lights Boulevard, Anchorage, Alaska AK 99508 or by phoning (907) 561-4421. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Vax-D Treatment Center of Alaska |
| Contact Person: | Christopher Hogan, Owner |
| Address: | 1100 East Northern Lights Boulevard, Anchorage, Alaska 99508 |
| Phone Number: | (907) 561-4421 |
| Annual Revenue (USD): | $500.000 to $999.999 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2C (Business to Consumer) |
| Business Category: | Chiropractors |
| SIC Code: | 8041 |
| NAICS Code: | 6213100 |
| Share This Business: |
Vax-D Treatment Center of Alaska was started in 0 to provide professional Chiropractors under the SIC code 8041 and NAICS code 6213100. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $500.000 to $999.999 per annum.
Feel free to contact Christopher Hogan, Owner for inquiries that concern Vax-D Treatment Center of Alaska by calling the company number (907) 561-4421, as your correspondence is most welcome. Additionally, the physical location of the single location of Vax-D Treatment Center of Alaska can be found at the coordinates 61.19518,-149.8623 as well as the street address 1100 East Northern Lights Boulevard in Anchorage, Alaska 99508.
For its online presence, you may visit Vax-D Treatment Center of Alaska’s website at and engage with its social media outlets through on Twitter and on Facebook.